The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP39393) in vitro

S H Ibbotson, P J Grant, R Kerry, V S Findlay, C R Prentice

    Research output: Contribution to journalArticle

    38 Citations (Scopus)

    Abstract

    Hirudin is a specific, potent inhibitor of thrombin that may be a valuable antithrombotic agent. The aim of this study was to investigate the hypothesis that the haemostatic effects of DDAVP counteract the coagulation defect induced by hirudin. The effect of DDAVP was studied in vivo on the anticoagulant action of recombinant hirudin (CGP39393) in vitro. Blood samples were taken at intervals from 10 normal volunteers infused with DDAVP. Factor VIII:C rose from (mean) 0.68 IU/ml before DDAVP to 2.19 and 2.16 IU/ml after 30 and 60 min infusion, respectively. Samples taken during DDAVP infusion showed a dose related decrease in the hirudin (0.5 and 1.0 microM) induced prolongation of the APTT, that occurred at FVIII:C concentrations of up to twice normal. At higher concentrations of hirudin no effect on the APTT occurred. These results demonstrate that DDAVP infusion elevates factor VIII:C levels with an associated significant reduction in the anticoagulant effect of hirudin in vitro.
    Original languageEnglish
    Pages (from-to)64-66
    Number of pages3
    JournalThrombosis and Haemostasis
    Volume65
    Issue number1
    Publication statusPublished - 23 Jan 1991

    Keywords

    • Anticoagulants
    • Infusions, Intravenous
    • Recombinant Proteins
    • Humans
    • Deamino Arginine Vasopressin
    • Hirudins
    • Factor VIII
    • Partial Thromboplastin Time

    Fingerprint Dive into the research topics of 'The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP39393) in vitro'. Together they form a unique fingerprint.

  • Cite this